In models of nonalcoholic steatohepatitis (NASH), GLP-1 analogs have been shown to attenuate hepatic inflammation by reducing M1 macrophage infiltration and inhibiting NF-B activity, thereby lowering the expression of pro-inflammatory mediators such as IL-6, TNF-, and iNOS (Yusta et al., 2015)
Here are the most common ones and the tips I share with my clients to navigate them: Nausea: This is the most frequently reported side effect
It allows for sugar reduction, enhances nutritional profile, and offers functional benefits, improving taste, texture, and mouthfeel
Secondly, it reduces the new production of sugar , called gluconeogenesis
Both groups also received a lifestyle intervention
Dysregulated amino acid metabolism in heart failure: role of gut microbiome